Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison - Moreau, Philippe; Hebraud, Benjamin; Facon, Thierry; Leleu, Xavier; Hulin, Cyrille; Hashim, Mahmoud; Hu, Yannan; Caillot, Denis; Benboubker, Lofti; Zweegman, Sonja; Merz, Maximilian; Weisel, Katja; et al. (Immunotherapy, 2021)
Online veröffentlicht: 24 November 2020